THE WHAT? Procter & Gamble has reported its results for the first quarter of fiscal 2023. In the three months to September 30, 2022, net sales hit US$20.6 billion, up a flat 1 percent on the prior-year period. Net earnings per share were down US$1.57, down 2 percent on the previous year.
THE DETAILS Unfavorable foreign exchange has a six percent impact on net sales, the US FMCG manufacturer said, although all categories saw volume drop. The organic sales increase of 7 percent was driven by a 9 percent increase from higher pricing and one percent increase from positive product mix, partially offset by a three percent decrease in shipment volumes.
Beauty saw organic sales rise 4 percent versus the equivalent period in 2022 with skin and personal care organic sales up in the mid-single digits, offset by the decline of SK-II. Hair care organic sales increased in the mid-single digits.
THE WHY? Jon Moeller, Chairman of the Board, President and Chief Executive Officer, commented, “We delivered solid results in our first quarter of fiscal 2023 in a very difficult cost and operating environment. These results enable us to maintain our guidance ranges for organic sales and EPS growth for the fiscal year despite continued significant headwinds. We remain committed to our integrated strategies of a focused product portfolio, superiority, productivity, constructive disruption and an agile and accountable organization structure. These strategies have enabled us to build and sustain strong momentum. They remain the right strategies to navigate through the near-term challenges we’re facing and continue to deliver balanced growth and value creation.”
Injectable aesthetics are popular due to their ability to provide noticeable results with minimal downtime compared to surgical procedures. They are versatile and can be tailored to meet individual aesthetic goals, whether it's enhancing lips, restoring facial volume, or smoothing out wrinkles. However, they should always be administered by qualified professionals to ensure safety and achieve optimal results.
Injectable aesthetics are used to enhance facial features, reduce the signs of aging, and improve overall facial symmetry and appearance.
Key types of injectable aesthetics include:
-
Dermal Fillers: These injectables are used to add volume, fill in wrinkles and folds, and enhance facial contours. They often contain substances like hyaluronic acid, collagen, or calcium hydroxylapatite, which help plump up the skin and smooth out fine lines and wrinkles.
-
Botulinum Toxin (Botox): Botulinum toxin injections temporarily relax facial muscles that cause wrinkles and lines to form. It is commonly used to treat forehead lines, frown lines between the eyebrows, and crow's feet around the eyes.
-
Collagen Stimulators: These injectables stimulate the body's own collagen production, helping to improve skin texture and firmness over time. Examples include poly-L-lactic acid (Sculptra) and calcium hydroxylapatite (Radiesse).
-
Neurotoxin Injections: Besides Botox, other neurotoxins such as Dysport and Xeomin are used similarly to reduce wrinkles and lines.
